Insmed Incorporated
Orlov S Nicole Schaeffer (Chief People Strategy Officer) sells INSM shares
AI-generated summary
Chief People Strategy Officer Orlov S Nicole Schaeffer exercised 101,100 shares for $2,895,335 and sold 101,100 shares for $14,685,601.58 directly on November 19, 2026. After these transactions, the insider directly held 41,895 shares of Common Stock. The transactions were executed under a Rule 10b5-1 trading plan adopted on May 11, 2026.
Key facts
- Insider
- Orlov S Nicole Schaeffer · Chief People Strategy Officer
Rule 10b5-1 plan · adopted May 11, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 19, 2026 | M · exercise or conversion of a derivativeFootnotes F1, F2 | +55,400 | $30.46 | $1,687,484.00 | 97,295 | Direct |
| Nov 19, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +45,700 | $26.43 | $1,207,851.00 | 142,995 | Direct |
| Nov 19, 2026 | S · open-market saleFootnotes F1, F3 | −90,299 | $145.06 | $13,098,772.94 | 52,696 | Direct |
| Nov 19, 2026 | S · open-market saleFootnotes F1, F4 | −8,539 | $146.76 | $1,253,183.64 | 44,157 | Direct |
| Nov 19, 2026 | S · open-market saleFootnotes F1, F5 | −2,262 | $147.50 | $333,645.00 | 41,895 | Direct |
| Nov 19, 2026 | M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F6 | −55,400 | $0.00 | $0.00 | 0 | Direct |
| Nov 19, 2026 | M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F6 | −45,700 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- F2 Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
- F3 This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F4 This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F5 This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- F6 The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
More INSM filings
- 144
Filed Nov 19, 2026
- 144
Filed Nov 3, 2026
- 3
Filed Nov 3, 2026
- 8-K
Filed Oct 29, 2026
- 10-Q
Filed Oct 29, 2026
- 4
Filed Oct 20, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.